By Associate Professor Suzanne Jean Hodgkinson

Journal articles

Tran GT; Hodgkinson SJ; Carter N; Killingsworth M; Spicer ST; Hall BM, 2002, 'Attenuation of experimental allergic encephalomyelitis in complement component 6-deficient rats is associated with reduced complement C9 deposition, P-selectin expression, and cellular infiltrate in spinal cords', Journal of Immunology, 168, pp. 4293 - 4300, http://dx.doi.org/10.4049/jimmunol.168.9.4293

Hodgkinson SJ, 2001, 'Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?', Journal of Clinical Neuroscience, 8, pp. 378 - 379, http://dx.doi.org/10.1054/jocn.2001.0911

Spicer ST; Ha H; Boyd RA; He XY; Carter N; Tran GT; Penny MJ; Hodgkinson SJ; Hall BM, 2001, 'IL-4 Therapy Prevents the development of proteinuria in active Heymann Nephritis by inhibition of Tc1 cells', Journal of Immunology, 167, pp. 3725 - 3733

Tran GT; Carter N; Hodgkinson SJ, 2001, 'Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis', International Immunopharmacology, 1, pp. 1709 - 1723

Tran GT; Carter N; He XY; Spicer ST; Plain KM; Nicolls M; Hall BM; Hodgkinson SJ, 2001, 'Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAB therapy with a preferential effect on Th1 cells that is augmented by IL-4', International Immunology, 13, pp. 1109 - 1120

Hall BM; Hodgkinson SJ; Quin JW, 1999, 'Corticosteroids in Autoimmunity', Australian Prescriber, pp. 15 - 18

Hall BM; Hodgkinson SJ; Quin JW, 1998, 'Corticosteroids in autoimmune diseases.', Australian Prescriber, pp. 9 - 11

Van Oosten BW; Lai M; Hodgkinson S; Barkhof F; Miller DH; Moseley IF; Thompson AJ; Rudge P; McDougall A; McLeod JG; Adèr HJ; Polman CH, 1997, 'Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled, MR- monitored phase II trial', Neurology, 49, pp. 351 - 357, http://dx.doi.org/10.1212/WNL.49.2.351

Murwani R; Hodgkinson S; Armati P, 1996, 'Tumor necrosis factor α and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon γ stimulation', Journal of Neuroimmunology, 71, pp. 65 - 71, http://dx.doi.org/10.1016/S0165-5728(96)00131-2

Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J, 1996, 'Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis', Annals of Neurology, 39, pp. 6 - 16, http://dx.doi.org/10.1002/ana.410390104

Van Oosten BW; Lai M; Barkhof F; Miller DH; Moseley IF; Thompson AJ; Hodgkinson S; Polman CH, 1996, 'A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosis', Multiple Sclerosis, 1, pp. 339 - 342, http://dx.doi.org/10.1177/135245859600100611

Barkhof F; Thompson AJ; Hodgkinson S; van Oosten B; Lai M; Polman CH; McLeod J; Rudge P; Moseley IF; Ader H, 1995, 'Double-blind, placebo-controlled, MR monitored exploratory trial of chimeric anti-CD4 antibodies in MS.', Journal of Neuroimmunology, 56-63, pp. 15 - 15, http://dx.doi.org/10.1016/0165-5728(95)98902-n

Lindsey JW; Hodgkinson S; Mehta R; Siegel RC; Mitchell DJ; Lim M; Piercy C; Tram T; Dorfman L; Enzmann D; Steinman L, 1994, 'Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis', Neurology, 44, pp. 413 - 419, http://dx.doi.org/10.1212/wnl.44.3_part_1.413

Lindsey RJW; Hodgkinson S; Mehta R; Mitchell D; Enzmann D; Steinman L, 1994, 'Repeated treatment with chimeric anti‐CD4 antibody in multiple sclerosis', Annals of Neurology, 36, pp. 183 - 189, http://dx.doi.org/10.1002/ana.410360210

Hodgkinson SJ; Westland KW; Pollard JD, 1994, 'Transfer of experimental allergic neuritis by intra neural injection of sensitized lymphocytes', Journal of the Neurological Sciences, 123, pp. 162 - 172, http://dx.doi.org/10.1016/0022-510X(94)90219-4

Bell RB; Lindsey JW; Sobel RA; Hodgkinson S; Steinman L, 1993, 'Diverse T cell receptor Vβ gene usage in the central nervous system in experimental allergic encephalomyelitis', Journal of Immunology, 150, pp. 4085 - 4092

Steinman L; Lindsey JW; Alters S; Hodgkinson S, 1993, 'From treatment of experimental allergic encephalomyelitis to clinical trials in multiple sclerosis.', Immunology series, 59, pp. 253 - 260

Smilek DE; Wraith DC; Hodgkinson S; Dwivedy S; Steinman L; McDevitt HO, 1991, 'A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis', Proceedings of the National Academy of Sciences of the United States of America, 88, pp. 9633 - 9637

Knox SJ; Levy R; Hodgkinson S; Bell R; Brown S; Wood GS; Hoppe R; Abel EA; Steinman L; Berger RG; Gaiser C; Young G; Bindl J; Hanham A; Reichert T, 1991, 'Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoides', Blood, 77, pp. 20 - 30

Hodgkinson SJ; Pollard JD; McLeod JG, 1990, 'Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy', Journal of Neurology Neurosurgery and Psychiatry, 53, pp. 327 - 330, http://dx.doi.org/10.1136/jnnp.53.4.327

Sakai K; Zamvil SS; Mitchell DJ; Hodgkinson S; Rothbard JB; Steinman L, 1989, 'Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins', Proceedings of the National Academy of Sciences of the United States of America, 86, pp. 9470 - 9474, http://dx.doi.org/10.1073/pnas.86.23.9470

Back to profile page